Hypersensitivity	hypersensitivity	O	DISEASE	OTHERS	I
to	to	O	O	O	O
carbamazepine	carbamazepine	CHEMICALS	O	OTHERS	I
presenting	presenting	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
leukemoid	leukemoid	O	DISEASE	OTHERS	I
reaction	reaction	O	DISEASE	OTHERS	I
,	,	O	O	O	O
eosinophilia	eosinophilia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
erythroderma	erythroderma	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
a	a	O	O	O	O
patient	patient	O	O	O	O
in	in	O	O	O	O
whom	whom	O	O	O	O
hypersensitivity	hypersensitivity	O	DISEASE	OTHERS	I
to	to	O	O	O	O
carbamazepine	carbamazepine	CHEMICALS	O	OTHERS	I
presented	presented	O	O	O	O
with	with	O	O	O	O
generalized	generalized	O	O	O	O
erythroderma	erythroderma	O	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
severe	severe	O	O	O	O
leukemoid	leukemoid	O	DISEASE	OTHERS	I
reaction	reaction	O	DISEASE	OTHERS	I
,	,	O	O	O	O
eosinophilia	eosinophilia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
hyponatremia	hyponatremia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

This	this	O	O	O	O
is	is	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
report	report	O	O	O	O
of	of	O	O	O	O
such	such	O	O	O	O
an	an	O	O	O	O
unusual	unusual	O	O	O	O
reaction	reaction	O	O	O	O
to	to	O	O	O	O
carbamazepine	carbamazepine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

